A polymorphism in the gene encoding the Fcgamma IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis.
Tsukahara
S
S
Ikari
K
K
Sato
E
E
Yamanaka
H
H
Hara
M
M
Tomatsu
T
T
Momohara
S
S
Kamatani
N
N
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D017452:Receptors, IgG / Q000235:genetics*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; C496124:FCGR3A protein, human; D005819:Genetic Markers; D017452:Receptors, IgG; D000069285:Infliximab